Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Journal of Medicinal Chemistry|January 15, 2014
Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseasesJames D Clark, Mark E Flanagan, Jean-Baptiste TelliezPsychology of Sport and Exercise|September 4, 2023
Understanding mental toughness at a Women's Australian rules football clubJames D Clark, Clifford J Mallett, Gene M Moyle, et al.Journal of Sports Sciences|January 22, 2023
Competitive Situations Requiring Mental Toughness in Women's Australian Rules FootballJames D Clark, Clifford J Mallett, Gene M Moyle, et al.Sports Medicine - Open|June 13, 2023
The Perceptions of Elite Professional Rugby League Players and Staff on the National Rugby League Annual Calendar: A Mixed-Methods StudyLewis A Fazackerley, Geoffrey M Minett, James D Clark, et al.Assay and Drug Development Technologies|January 21, 2010
A human CXCL13-induced actin polymerization assay measured by fluorescence plate readerJennifer Alley, Laird Bloom, Marion Kasaian, et al.Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|April 3, 2015
Milbemycin oxime (Interceptor) treatment of amphipod parasites (Hyperiidae) from several host jellyfish speciesJennifer L Boonstra, Maureen E Koneval, James D Clark, et al.The Journal of Experimental Medicine|May 14, 2003
Cytosolic phospholipase A2alpha-deficient mice are resistant to collagen-induced arthritisMartin Hegen, Linhong Sun, Naonori Uozumi, et al.Bioorganic & Medicinal Chemistry Letters|March 21, 2006
1,2,4-Oxadiazolidin-3,5-diones and 1,3,5-triazin-2,4,6-triones as cytosolic phospholipase A2alpha inhibitorsAriamala Gopalsamy, Hui Yang, John W Ellingboe, et al.Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Structure-activity relationships of indole cytosolic phospholipase A(2)alpha inhibitors: substrate mimeticsJohn C McKew, Frank Lovering, James D Clark, et al.Clinical and Experimental Rheumatology|March 12, 2016
The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritisJennifer A Hodge, Thomas T Kawabata, Sriram Krishnaswami, et al.Pageof 5